|
⚲
|
| Keyboard |
| McGrath Lynne Fahey
✚
|
|
|---|---|
| CIK # | 0001866270 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001866270] | |
| 4 | [0001866270] | |
| 5 | [0001866270] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Alzamend Neuro Inc | |
| McGrath Lynne Fahey |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alzamend Neuro Inc ALZN
Common Stock
|
2025-10-23 | Sell | 30 | $2.29 | 69 |
|
Alzamend Neuro Inc ALZN
Common Stock
|
2023-12-26 | Sell | 666 | $0.88 | 586 |
|
Alzamend Neuro Inc ALZN
Common Stock
|
2023-03-22 | Buy | 10,000 | $0.44 | 4,400 |
|
Alzamend Neuro Inc ALZN
Common Stock
|
2022-03-28 | Sell | 25,000 | $1.21 | 30,250 |
|
Alzamend Neuro Inc ALZN
Common Stock
|
2022-03-15 | Option exercise | 50,000 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Restricted Stock Grant · derivative
|
2022-03-15 | Option exercise | 50,000 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Common Stock
|
2021-10-15 | Option exercise | 47,222 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Restricted Stock Grant · derivative
|
2021-10-15 | Option exercise | 47,222 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Restricted Stock Grant · derivative
|
2021-09-13 | Option exercise | 2,778 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Common Stock
|
2021-09-13 | Option exercise | 2,778 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Stock Options (Right to Buy) · derivative
|
2021-06-15 | Grant | 300,000 | $0.00 | |
|
Alzamend Neuro Inc ALZN
Restricted Stock Grant · derivative
|
2021-06-15 | Grant | 100,000 | $0.00 |